A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
about
Risperidone versus other atypical antipsychotics for schizophreniaClozapine versus other atypical antipsychotics for schizophreniaPrevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-AnalysisOxytocin in schizophrenia: a review of evidence for its therapeutic effects.An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients.A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data.Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacologyComparison of clozapine response for inpatients in the research setting versus routine clinical practiceClozapine: Current perspective.Clinical features of schizophrenia with enhanced carbonyl stress.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Almost all antipsychotics result in weight gain: a meta-analysis.Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial.Understanding antipsychotic "atypicality": a clinical and pharmacological moving targetStrong Treatment Response and High Maintenance Rates of Clozapine in Childhood-Onset Schizophrenia.Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design featuresImpact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophreniaThe incidence and characteristics of clozapine- induced fever in a local psychiatric unit in Hong Kong.Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.Pharmacoeconomics of antipsychotic medications.Clozapine for the treatment of schizophrenia.Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses.Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis.Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management.Atypical antipsychotics: revolutionary or incremental advance?Trends in antipsychotic prescribing in schizophrenia in Auckland.Clozapine administration in clinical practice: once-daily versus divided dosing.Concept and Management of Treatment Resistant Schizophrenia (TRS)Clozapine: a distinct, poorly understood and under-used molecule.Current status of clozapine in the United States.A naturalistic study of risperidone treatment in seven affiliated university hospitals in Korea.Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study.Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin.Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patients.Clozapine and Gastrointestinal Hypomotility.The Black Book of Psychotropic Dosing and Monitoring.
P2860
Q24234950-5C270AEF-3388-4163-8D4E-12E7FE5D879CQ24236422-F47DA29C-1110-45D4-83AA-A825193142ADQ26748476-9E5644B2-06BE-4CD8-A79D-74485CFB128AQ30453929-EC31498C-7878-42C3-8D9B-3237690FF38AQ30491026-5E67D3A2-948B-4299-BF3D-C3269AEE5751Q30667146-34754DA6-4D19-4464-9388-2857F18DE86CQ30882594-02681278-E880-40F0-8D7C-FCEEE4481478Q33223628-C1EF91E9-858C-4901-8C85-B635F9676D30Q33538059-109A3353-9ACC-42E3-8DE7-45A11623A959Q33994937-15B14813-DBFA-49E8-9DCA-EDD4DEE25284Q34021447-3771A1BC-1604-43C5-9022-976B2C502252Q34048575-F56B34BF-75E3-472F-BE09-A1840BE7DBC9Q34640811-37650E21-47C6-4B6D-8B9F-21ABE54D67AFQ34661499-5BB133F1-1F6F-4B3A-9E36-E8067B26997CQ34716524-4016CFAC-9405-426A-A488-520B6FF78CE0Q35200831-E79A4A14-15BF-4E4E-93B8-C2E0B127464FQ37061154-759B3934-3862-4181-8C2E-6B8545A9EDA2Q37061277-2B647DF1-71E1-437D-9429-60A002E84B93Q37224949-237F1835-0483-44E1-82AD-FFA64C087EF9Q37227479-F9D0B89F-AB8A-401C-BCA3-ABB20592A07CQ37315451-A0AB2EBD-9E36-44A3-AF18-325E8DC577E6Q37352352-8C79FF73-7BCB-4F2F-84D6-A28F56C10902Q37532575-0A75EB98-22A7-40A1-9430-86B730A6B3C4Q37609263-F47C761B-6D43-4FE1-B427-7796C7A638B0Q38026886-2267F716-C946-4CF2-B081-9C68D67FFD09Q38068636-327A24AD-58FA-4111-A38D-046204FE337DQ38706468-77EB3ABB-5683-487A-B64C-7C2720C890BDQ38884279-80C0F54D-DE0A-4CEC-90B8-177622AD98A9Q39412178-DA718D3A-26C4-4208-B532-BAD72475C4BBQ39756918-39C14E51-BC83-45D7-875E-02F59959C7CBQ39763748-CED737C9-87CA-48E4-848B-017078AFD2BBQ40521264-EAF8A33B-5191-46AA-B84F-EB7D0CB8B04BQ42807652-F48FB232-DB55-4455-899D-E6A99BBF4E56Q42946206-FC29F75C-1CA2-4365-8458-3E77B6F03658Q44272988-F8E5346F-07F4-4F3E-9E36-628638922B35Q45257716-1B5E006E-F31F-4CB5-840A-52DE7CFA8A08Q46411318-1BBD590B-CD72-4787-ABCB-4CCCF45B9A52Q46471571-E5E4D060-2AF3-4E7E-95D9-2A3DA8BCC818Q47565362-1FFE610C-8410-4BFB-BD32-9C61E5027486Q47642128-50C75C39-4633-4788-9EFA-A47C1332842F
P2860
A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A double-blind comparative stu ...... severe chronic schizophrenia.
@en
A double-blind comparative stu ...... severe chronic schizophrenia.
@nl
type
label
A double-blind comparative stu ...... severe chronic schizophrenia.
@en
A double-blind comparative stu ...... severe chronic schizophrenia.
@nl
prefLabel
A double-blind comparative stu ...... severe chronic schizophrenia.
@en
A double-blind comparative stu ...... severe chronic schizophrenia.
@nl
P2093
P1476
A double-blind comparative stu ...... severe chronic schizophrenia.
@en
P2093
Bourdeix I
Remington G
Vanelle JM
P304
P356
10.1176/APPI.AJP.158.8.1305
P407
P577
2001-08-01T00:00:00Z